Norges Bank Blueprint Medicines Corp Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

47 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$85.18 - $108.78 $50.4 Million - $64.4 Million
592,126 New
592,126 $63.8 Million
Q4 2023

Feb 09, 2024
BUY
$43.96 - $92.84 $26.6 Million - $56.3 Million
605,951 New
605,951 $55.9 Million
Q3 2023

Nov 13, 2024
BUY
$46.9 - $66.0 $27.5 Million - $38.7 Million
585,996 New
585,996 $29.4 Million
Q3 2023

Nov 13, 2023
SELL
$46.9 - $66.0 $37.1 Million - $52.2 Million
-790,955 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$42.2 - $66.37 $799,268 - $1.26 Million
-18,940 Reduced 3.2%
573,186 $36.2 Million
Q2 2023

Aug 14, 2023
SELL
$42.2 - $66.37 $25.9 Million - $40.8 Million
-614,901 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$37.97 - $50.0 $21.3 Million - $28 Million
560,792 New
560,792 $25.2 Million
Q4 2022

Feb 14, 2023
BUY
$41.06 - $66.48 $26 Million - $42.2 Million
634,045 New
634,045 $27.8 Million
Q3 2022

Nov 13, 2023
BUY
$49.93 - $77.7 $39.5 Million - $61.5 Million
790,955 New
790,955 $52.1 Million
Q2 2022

Aug 14, 2023
BUY
$45.23 - $70.15 $27.8 Million - $43.1 Million
614,901 New
614,901 $31.1 Million
Q1 2022

May 12, 2023
BUY
$54.1 - $110.08 $9.98 Million - $20.3 Million
184,412 Added 29.09%
818,457 $52.3 Million
Q1 2022

May 09, 2022
SELL
$54.1 - $110.08 $43.6 Million - $88.7 Million
-806,188 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$94.25 - $115.99 $76 Million - $93.5 Million
806,188 New
806,188 $86.4 Million
Q3 2021

Nov 14, 2022
BUY
$80.98 - $109.47 $59.7 Million - $80.7 Million
737,157 New
737,157 $75.8 Million
Q3 2021

Nov 05, 2021
SELL
$80.98 - $109.47 $54.5 Million - $73.7 Million
-672,973 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$82.78 - $101.0 $55.7 Million - $68 Million
672,973 New
672,973 $59.2 Million
Q2 2021

Aug 10, 2021
SELL
$82.78 - $101.0 $58.8 Million - $71.7 Million
-709,908 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$90.71 - $108.28 $64.4 Million - $76.9 Million
709,908 New
709,908 $69 Million
Q1 2021

May 07, 2021
SELL
$90.71 - $108.28 $70.8 Million - $84.5 Million
-780,264 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$92.08 - $124.48 $71.8 Million - $97.1 Million
780,264 New
780,264 $87.5 Million
Q4 2020

Feb 10, 2021
SELL
$92.08 - $124.48 $90.2 Million - $122 Million
-979,314 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$66.45 - $92.7 $65.1 Million - $90.8 Million
979,314 New
979,314 $90.8 Million
Q3 2020

Nov 10, 2020
SELL
$66.45 - $92.7 $76.9 Million - $107 Million
-1,156,671 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$57.09 - $79.27 $66 Million - $91.7 Million
1,156,671 New
1,156,671 $90.2 Million
Q2 2020

Aug 07, 2020
SELL
$57.09 - $79.27 $89.6 Million - $124 Million
-1,569,812 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$48.11 - $82.22 $75.5 Million - $129 Million
1,569,812 New
1,569,812 $91.8 Million
Q1 2020

May 08, 2020
SELL
$48.11 - $82.22 $48 Million - $82 Million
-997,612 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$66.73 - $82.59 $66.6 Million - $82.4 Million
997,612 New
997,612 $79.9 Million
Q4 2019

Feb 12, 2020
SELL
$66.73 - $82.59 $48.9 Million - $60.5 Million
-732,212 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$72.9 - $101.41 $53.4 Million - $74.3 Million
732,212 New
732,212 $53.8 Million
Q3 2019

Nov 08, 2019
SELL
$72.9 - $101.41 $56.5 Million - $78.6 Million
-775,544 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$73.54 - $97.8 $57 Million - $75.8 Million
775,544 New
775,544 $73.2 Million
Q2 2019

Aug 09, 2019
SELL
$73.54 - $97.8 $65.9 Million - $87.6 Million
-895,544 Closed
0 $0
Q1 2019

May 11, 2020
BUY
$48.7 - $86.6 $5.04 Million - $8.95 Million
103,393 Added 13.05%
895,544 $71.7 Million
Q4 2018

Mar 04, 2019
BUY
$45.57 - $74.26 $36.1 Million - $58.8 Million
792,151 New
792,151 $42.7 Million
Q4 2018

Feb 08, 2019
SELL
$45.57 - $74.26 $36.1 Million - $58.8 Million
-792,151 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$58.91 - $78.32 $46.7 Million - $62 Million
792,151 New
792,151 $61.8 Million
Q3 2018

Nov 09, 2018
SELL
$58.91 - $78.32 $54.6 Million - $72.6 Million
-927,333 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$60.96 - $101.18 $56.5 Million - $93.8 Million
927,333 New
927,333 $58.9 Million
Q2 2018

Jul 23, 2018
SELL
$60.96 - $101.18 $49.5 Million - $82.1 Million
-811,752 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$73.28 - $102.95 $59.5 Million - $83.6 Million
811,752 New
811,752 $74.4 Million
Q1 2018

May 09, 2018
SELL
$73.28 - $102.95 $56.9 Million - $80 Million
-776,734 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$62.91 - $88.32 $48.9 Million - $68.6 Million
776,734 New
776,734 $58.6 Million
Q4 2017

Feb 09, 2018
SELL
$62.91 - $88.32 $29.2 Million - $41 Million
-463,695 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$42.37 - $69.67 $19.6 Million - $32.3 Million
463,695 New
463,695 $32.3 Million
Q3 2017

Nov 07, 2017
SELL
$42.37 - $69.67 $15.9 Million - $26.1 Million
-375,000 Closed
0 $0
Q2 2017

Jul 24, 2018
BUY
N/A
375,000
375,000 $19 Million

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email